FAQs & How to use this site
Home | About Us | Contact Us
The Front Line

 

The Front Line: Charles D. Blanke, MD, SWOG Chair
ABOUT

PREVIOUS POSTS November 2017

October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

Impact of Hope VA Support Program Grows

November 17, 2017 - This is the third year we’re announcing $25,000 grants to U.S. Department of Veterans Affairs medical centers, in an effort to give more military veterans access to cutting-edge treatments being tested in National Clinical Trials Network research studies.

The Hope Foundation funds are aimed at building or expanding infrastructure – typically for front-line staff critical for running a cancer trial. You all know clinical research associates and oncology nurses are crucial to conducting studies. They discuss the day-to-day operations with patients, assist with tissue and data submissions, and perform many other necessary tasks. These research professionals are in particularly short supply at VA medical centers.

This year’s VA Integration Support Program awards go to:

    • South Texas Veterans Healthcare System, San Antonio, TX

    • VA Central California Health Care System, Fresno, CA

    • VA Medical Center New Orleans, New Orleans, LA

    • W.G. (Bill) Hefner VA Medical Center, Salisbury, NC

Hope has now awarded $350,000 through the VA Integration Support Program, seeding research support at a total of 14 VAs, located in 12 states, from New York to Florida to Washington. Nearly all these hospitals now have the staff and CIRB arrangements to offer NCTN clinical trials, including our own Lung-MAP and the NCI-MATCH study.

In the past three years since our program began, 95 patients at VA medical centers in the U.S. were enrolled in SWOG or SWOG-credited clinical trials. That’s a 300 percent increase from enrollments from VA centers prior to the program launch. Given the start-up time for new hires and to activate trials, we think this is a significant improvement.

What’s even more exciting is the release this week of a request for applications for a new program similar to ours, but on a bigger scale. It’s the NCI and VA Interagency Group to Accelerate Trials Enrollment, or NAVIGATE. Like ours, this brand-new program is aimed at offering veterans the chance to participate in NCTN and NCI Community Oncology Research Program (NCORP) studies. And, like ours, the funding will pay for personnel to initiate NCTN and NCORP membership, open trials, execute agreements with the CIRB, and work collaboratively with other VA sites to identify appropriate studies for the veteran cancer patient population.

MAVERIC, the VA clinical research program and our partners in the VA Integration Support Program, will be running the new NAVIGATE program. We will work closely with them, ensuring that our programs work together to maximize impact, and to maximize patient access to oncology trials.

Hope is also working with us to tweak our program for 2018. We expect to double the VA grant amount to $50,000 and offer fewer awards. We aren’t trying to become parsimonious. We have just realized successful centers need more funds to predictably cover staff costs. I’m thrilled that in just three years, we’re starting to make a real difference in trial access to a patient population who deserve the best our health care system has to offer – NCTN research.

SWOG's new website launches November 28, and you'll need proper credentials to log-in. Check for details.

 
     
SWOG Logo Disclaimer | Copyright ©1999-2017 SWOG. All rights reserved.
Design and Hosting by nuMedia
SWOG is FISMA CertifiedSWOG is FISMA Certified